drugset / Trial / NCT01511315
The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment
NaSingle-groupOpen-labelTreatment
Summary
This study aims to see if patient quality of life can be approved after treatment with an injectable medication called ustekinumab for the treatment of generalized psoriasis. The investigators hypothesize that the investigators will see improvement in quality of life.
Timeline
- Start
- 2012-03
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ustekinumab | Monoclonal antibody | — | Subcutaneous |